Johnson & Johnson (JNJ) FCF Margin (2009 - 2026)
Johnson & Johnson (JNJ) posted FCF Margin of 28.82% for Q2 2026, up 373.4% sequentially from 6.09% in Q1 2026, and up 1688.0% YoY from 1.61% in Q2 2025.
Johnson & Johnson (JNJ) FCF Margin (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported FCF Margin for 18 years, with the latest figure at 28.82% in Q2 2026.
- Quarterly FCF Margin rose 1688.0% year-over-year to 28.82% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 22.71% (up 225.0% YoY) and the FY2025 annual result came in at 20.91%, down 143.0% from the prior year.
- FCF Margin improved to 28.82% in Q2 2026 per JNJ's latest filing, from 6.09% in the prior quarter.
- Over five years, FCF Margin peaked at 33.39% in Q3 2025 and troughed at 6.09% in Q1 2026.
- A 5-year average of 19.88% and a median of 18.87% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2026: FCF Margin soared 2058 bps in 2023, then sank 935 bps in 2026.
- Over 5 years, FCF Margin stood at 17.0% in 2022, then jumped by 73 bps to 29.32% in 2023, then decreased by 19 bps to 23.85% in 2024, then declined by 7 bps to 22.28% in 2025, then gained by 29 bps to 28.82% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 28.82%, 6.09%, and 22.28% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 38.60% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | -12.07% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 2.01% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 3.90% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 28.82% |
| Mar 29, 2026 | 6.09% |
| Dec 28, 2025 | 22.28% |
| Sep 28, 2025 | 33.39% |
| Jun 29, 2025 | 11.94% |
| Mar 30, 2025 | 15.43% |
| Dec 29, 2024 | 23.85% |
| Sep 29, 2024 | 30.99% |
| Jun 30, 2024 | 20.75% |
| Mar 31, 2024 | 13.33% |
| Dec 31, 2023 | 29.32% |
| Oct 1, 2023 | 30.55% |
| Jul 2, 2023 | 14.21% |
| Apr 2, 2023 | 11.46% |
| Jan 1, 2023 | 8.75% |
| Apr 3, 2022 | 17.00% |
| Oct 3, 2021 | 32.32% |
| Jul 4, 2021 | 19.31% |
| Apr 4, 2021 | 15.22% |
| Jan 3, 2021 | 31.23% |